1. Intravenous delivery of the toll-like receptor 7 agonist SC1 confers tumor control by inducing a CD8+ T cell response. (3rd July 2019) Authors: Vascotto, Fulvia; Petschenka, Jutta; Walzer, Kerstin C.; Vormehr, Mathias; Brkic, Magdalena; Strobl, Stefan; Rösemann, Roman; Diken, Mustafa; Kreiter, Sebastian; Türeci, Özlem; Sahin, Ugur Journal: Oncoimmunology Issue: Volume 8:Number 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗